Javascript must be enabled to continue!
Ovarian Cancer Immunotherapy
View through CrossRef
Ovarian Cancer Immunotherapy provides a broad overview of several aspects of basic sciences and clinical and therapeutic aspects of immunotherapy for ovarian cancer, as well as state-of-the-art information on molecular genetics and biology. Chapters are written by a team of expert contributors from around the world and explore topics such as antibody therapeutics for ovarian carcinoma, emerging serum biomarkers, ovarian cancer immunity, adoptive cell immunotherapy, the biology of dendritic cells, the role of growth factors, and more. Readers will also gain a better understanding of the molecular and cellular events that underlie ovarian cancer immunology. This book is an ideal reference for clinicians and medical students caring for patients with ovarian cancer, including attending surgeons and physicians, and clinical fellows and residents in the disciplines of gynecologic oncology, medical oncology, and surgical oncology.
Title: Ovarian Cancer Immunotherapy
Description:
Ovarian Cancer Immunotherapy provides a broad overview of several aspects of basic sciences and clinical and therapeutic aspects of immunotherapy for ovarian cancer, as well as state-of-the-art information on molecular genetics and biology.
Chapters are written by a team of expert contributors from around the world and explore topics such as antibody therapeutics for ovarian carcinoma, emerging serum biomarkers, ovarian cancer immunity, adoptive cell immunotherapy, the biology of dendritic cells, the role of growth factors, and more.
Readers will also gain a better understanding of the molecular and cellular events that underlie ovarian cancer immunology.
This book is an ideal reference for clinicians and medical students caring for patients with ovarian cancer, including attending surgeons and physicians, and clinical fellows and residents in the disciplines of gynecologic oncology, medical oncology, and surgical oncology.
Related Results
Prevention of cancer
Prevention of cancer
In the UK, the four commonest cancers—lung cancer, breast cancer, colon cancer, and prostate cancer—result in around 62 000 deaths every year. Although deaths from cancer have fall...
PD-1/PDL-1 Inhibitors as Immunotherapy for Ovarian Cancer
PD-1/PDL-1 Inhibitors as Immunotherapy for Ovarian Cancer
Programmed death 1 (PD-1), a member of the B7-CD28 immunoglobulin superfamily, and its ligands PD-L1/PD-L2 inhibit T-cell activation. They also play a key role in the tumor microen...
Clinical approach to suspected cancer
Clinical approach to suspected cancer
Lung cancer 4Breast cancer 5Urological cancer 6Nervous system tumours 7Upper gastrointestinal cancer 8Lower gastrointestinal cancer 9Gynaecological cancer 10Haematological cancer 1...
Principles of oncogenesis
Principles of oncogenesis
It is obvious that the process of developing cancer—oncogenesis—is a multistep process. We know that smoking, obesity, and a family history are strong independent predictors of dev...
Screening for cancer
Screening for cancer
The aim in cancer screening is not just to prevent the incidence of disease or diagnose it in an early stage but, most importantly, to reduce mortality. Designing screening program...
After You Hear It's Cancer
After You Hear It's Cancer
In 2014, an estimated 1.66 million people will receive a diagnosis of cancer. They will join a pool of 13.7 million Americans already living with a history of cancer. Almost 600,00...
Oxford Textbook of Colorectal Cancer
Oxford Textbook of Colorectal Cancer
Abstract
Colorectal cancer remains one of the most common cancers in both men and women globally with almost 2 million cases and 1 million deaths per year. The mo...

